Education
About Us
Working with TipRanks
Follow Us
Generation Bio Co. (GBIO)
NASDAQ:GBIO
Total Valuation
Generation Bio has a market cap or net worth of $24.65M. The enterprise value is $73.85M.
Market Cap$24.65M
Enterprise Value$73.85M
Share Statistics
Generation Bio has 67.01M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding67.01M
Owned by Insiders17.71%
Owned by Instutions26.37%
Financial Efficiency
Generation Bio’s return on equity (ROE) is -1.53 and return on invested capital (ROIC) is -68.08%.
Return on Equity (ROE)-152.74%
Return on Assets (ROA)-56.95%
Return on Invested Capital (ROIC)-68.08%
Return on Capital Employed (ROCE)-72.60%
Revenue Per Employee$161,582.609
Profits Per Employee-$1,264,973.913
Employee Count115
Asset Turnover0.09
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Generation Bio is -0.54. Generation Bio’s PEG ratio is -0.53.
PE Ratio-0.54
PS Ratio3.55
PB Ratio0.82
Price to Fair Value0.82
Price to FCF-0.78
Price to Operating Cash Flow-0.80
PEG Ratio-0.53
Income Statement
In the last 12 months, Generation Bio had revenue of $18.58M and earned -$145.47M in profits. Earnings per share was -$2.19.
Revenue$18.58M
Gross Profit$14.04M
Operating Income-$98.41M
Pretax Income-$145.47M
Net Income-$145.47M
EBITDA-92.47M
Earnings Per Share (EPS)-2.19
Cash Flow
In the last 12 months, operating cash flow was -$97.76M and capital expenditures -$6.60M, giving a free cash flow of -$104.36M billion.
Operating Cash Flow-$97.76M
Free Cash Flow-$104.36M
Free Cash Flow per Share-$1.56
Dividends & Yields
Generation Bio pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-128.80%
Earnings Yield-186.44%
Stock Price Statistics
Beta2.75
52-Week Price Change-85.97%
50-Day Moving Average0.51
200-Day Moving Average1.64
Relative Strength Index (RSI)43.24
Average Volume (3m)520.41K
Important Dates
Generation Bio upcoming earnings date is May 1, 2025, Before Open.
Last Earnings DateMar 13, 2025
Next Earnings DateMay 1, 2025
Ex-Dividend Date―
Financial Position
Generation Bio as a current ratio of 5.50, with Debt / Equity ratio of 1.09
Current Ratio5.50
Quick Ratio5.50
Debt to Market Cap1.32
Net Debt to EBITDA-0.12
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Generation Bio has paid $6.66M in taxes.
Income Tax$6.66M
Effective Tax Rate0.00%
Enterprise Valuation
Generation Bio EV to EBITDA ratio is -0.62, with an EV/FCF ratio of -0.97.
EV to Sales4.42
EV to EBITDA-0.62
EV to Free Cash Flow-0.97
EV to Operating Cash Flow-0.99
Balance Sheet
Generation Bio has $184.77M in cash and marketable securities with $93.78M in debt, giving a net cash position of -$90.99M billion.
Cash & Marketable Securities$184.77M
Total Debt$93.78M
Net Cash-$90.99M
Net Cash Per Share-$1.36
Tangible Book Value Per Share$1.29
Margins
Gross margin is 100.00%, with operating margin of -715.82%, and net profit margin of -661.91%.
Gross Margin100.00%
Operating Margin-715.82%
Pretax Margin-661.91%
Net Profit Margin-661.91%
EBITDA Margin-715.82%
EBIT Margin0.00%
Analyst Forecast
The average price target for Generation Bio is $7.33, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$7.33
Price Target Upside1779.49%
Analyst ConsensusModerate Buy
Analyst Count5
Revenue Growth Forecast236.92%
EPS Growth Forecast-0.57%